Minoxidil in Severe and Moderately Severe Hypertension, in Association with Methyldopa and Chlortalidone

Cotorruelo, Julio G.; Liamazares, C�sar; Fl�rez, Jesus
November 1982
Angiology;Nov1982, Vol. 33 Issue 11, p710
Academic Journal
Minoxidil is a potent antihypertensive drug widely used in severe arterial hypertension and in that refractory to treatment. Its effectiveness in less severe forms of hypertension was evaluated in 15 patients who had either a severe to moderate arterial hypertension not previously treated, or who did not tolerate the side effects of other antihypertensive drugs. The usefulness of methyldopa and chlortalidone to prevent a potential minoxidil-induced tachycardia and fluid retention, respectively, was also tested. The patients were initially treated with chlortalidone 100 mg/day, and methyldopa 500 mg/day. Minoxidil was then given in increasing doses until the diastolic blood pressure was equal to or inferior to 90 mmHg. This occurred consistently at doses which ranged from 5 to 50 mg/day (average, 29 mg). Treatment with minoxidil was continued for four months; tolerance to the drugs was not observed. Low doses of methyl- dopa and chlortalidone were effective in controlling the tachycardia and the retention of sodium and water induced by minoxidil. The three associated drugs were well tolerated and the life quality improved in most patients. Hypertrichosis was the most consistent side effect. Two patients were with- drawn from the study after the blood pressure was controlled by minoxidil, because of the appearance of angor in one, and edema and heart failure in the other.


Related Articles

  • Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study. Shapiro, Jerry // Journal of Cutaneous Medicine & Surgery;Jul/Aug2003, Vol. 7 Issue 4, p322 

    Background: Topical minoxidil solution (TMS) is widely used for androgenetic alopecia (AGA), and this is the first report of a large safety trial. Objectives: The aim of the study was to evaluate the safety profile of TMS by comparing hospitalization and death rates among subjects using TMS with...

  • Perindopril: the evidence of its therapeutic impact in hypertension. Thomson, Andrew; Greenacre, Mary // Core Evidence;2007, Vol. 2 Issue 1, p63 

    Introduction: Effective antihypertensive therapy reduces the risk of cardiovascular and cerebrovascular disease and death. Perindopril, a long-acting angiotensin-converting enzyme (ACE) inhibitor, is an established antihypertensive agent administered as a once-daily tablet. Aims: To review...

  • minoxidil. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p509 

    An encyclopedia entry for "minoxidil" is presented. It is a vasodilator drug used to treat severe hypertension. Hair growth, especially on the face, is stimulated by a prolonged use of the drug. This side effect is beneficial for male-pattern baldness. to stimulate hair regrowth, preparations...

  • Agent for hair growth available in two concentrations. Meszaros, Liz // Dermatology Times;Oct95, Vol. 16 Issue 10, p24 

    Reports that topical minoxidil in concentrations of two percent and five percent stimulates increases in hair weight, anagen growth and hair protein production. Retardation of hair thinning; Distinction of the effects of the two concentrations.

  • Minoxidil.  // Reactions Weekly;Jul2014, Vol. 1511 Issue 1, p32 

    The article informs that a study entitled "Minoxidil induced hypertrichosis in children" was published in the June 2014 issue of the "Journal der Deutschen Dermatologischen Gesellschaft."

  • Rogaine Launches New Treatment for Women.  // MMR;2/23/2015, Vol. 32 Issue 4, p18 

    The article reports that hair re-growth medication brand Rogaine has launched a hair re-growth treatment using Minoxidil called Women'sRogaine 5% Minoxidil Topical Aerosol.

  • Minoxidil in the Treatment of Refractory Hypertension. Rosenthal, Talma; Swartz, Jacob; Teicher, Avishai; Boichis, Hayim // Angiology;Feb1980, Vol. 31 Issue 2, p109 

    Minoxidil, a powerful vasodilator, is a very effective antihypertensive drug. It was used to treat 22 patients, most of whom were refractory to conventional antihypertensive medication. There was a swift and definite drop of blood pressure in all cases. In 7 patients with renal disease, renal...

  • Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Chapman, Arlene B; Schwartz, Gary L; Boerwinkle, Eric; Turner, Stephen T // Kidney International;Mar2002, Vol. 61 Issue 3, p1047 

    Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Background. Determinants of inter-individual variation in blood pressure (BP) response to antihypertensive therapy remain largely unknown. Although differences in race, age and measures...

  • Antihypertensive Medication Nonadherence and Blood Pressure. Kuritzky, Louis // Internal Medicine Alert;8/15/2011 Supplement 2, p119 

    The article reports on the impact of daily adherence to antihypertensive medication on the control of blood pressure.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics